Axin forms a complex with adenomatous polyposis coli gene product (APC), glycogen synthase kinase-3b (GSK3b), and b-catenin through dierent binding sites and downregulates b-catenin. GSK-3b-dependent phosphorylation of APC-(1211-2075) which has the Axin-binding site was facilitated by Axin, but that of APC-(959-1338) which lacks the Axin-binding site was not. Axin-(298-506) or Axin-(298-832), which has the GSK-3b-and bcatenin-but not APC-binding sites, did not enhance GSK-3b-dependent phosphorylation of either APC-(1211-2075) or APC-(959-1338). Furthermore, b-catenin stimulated the phosphorylation of APC-(959-1338) and APC-(1211-2075) by GSK-3b in the presence of Axin. Consistent with these in vitro observations, expression of b-catenin or Axin in COS cells promoted an SDS gel band shift of APC. These results indicate that APC complexed with Axin is eectively phosphorylated by GSK-3b and that b-catenin may modulate this phosphorylation. In addition, the heterodimeric form of protein phosphatase 2A (PP2A) directly bound to Axin, and PP2A complexed with Axin dephosphorylated APC phosphorylated by GSK-3b. Taken together, these results suggest that GSK-3b-dependent phosphorylation of APC can be modulated by b-catenin and PP2A complexed with Axin. Oncogene (2000) 19, 537 ± 545.
Introduction
Adenomatous polyposis coli gene product (APC) is a tumor suppressor linked to familial adenomatous polyposis (FAP) and to the initiation of sporadic human colorectal cancer (Polakis, 1997) . APC encodes a 300 kDa multifunctional protein with several structural domains. The N-terminus contains an oligomerization domain followed by seven repeats of an Armadillo motif. The middle portion of APC contains three successive 15-amino acid (aa) repeats followed by seven related but distinct 20-aa repeats, both of which are able to bind independently to b-catenin (Su et al., 1993; Rubinfeld et al., 1993 Rubinfeld et al., , 1995 . Following the 20-aa repeats is a basic region, while the C-terminus has a S/ TXV motif that interacts with the PDZ domaincontaining human homolog Dlg (Matsumine et al., 1996) . In FAP and colorectal cancers, most patients carry APC mutations which result in the expression of truncated proteins (Polakis, 1997) . Almost all mutant proteins lack the C-terminal half region including most of the 20-aa repeats but retain the 15-aa repeats. Colorectal carcinoma cells with this APC mutant contain a large amount of monomeric b-catenin . Indeed, APC downregulates the level of cytoplasmic b-catenin when introduced into colorectal cancer cell line, SW480 cells . This APC activity was localized to the central region of the protein and at least three 20-aa repeats are necessary for the degradation of b-catenin (Polakis, 1997; Rubinfeld et al., 1997) . However, the role of APC in the downregulation of b-catenin is not clear.
b-catenin has been originally identi®ed as a protein which interacts with cytoplasmic domain of cadherin and links cadherin to a-catenin, which in turn mediates the anchorage of the cadherin complex to the cortical actin cytoskeleton (Takeichi, 1991) . Many binding partners of b-catenin have been found, suggesting that b-catenin has additional functions outside cell ± cell adhesion. Genetic and embryological studies have clari®ed that b-catenin is a component of the Wnt signaling pathway and that it exhibits signaling functions (Cadigan and Nusse, 1997; Dale, 1998) . Current model provides that in the absence of Wnt, glycogen synthase kinase-3b (GSK-3b) acts to cause bcatenin to be phosphorylated and that the phosphorylated b-catenin is complexed with b-TrCP and ubiquitinated, leading to the degradation by the proteasome (Aberle et al., 1997; Kitagawa et al., 1999; Winston et al., 1999) . In response to Wnt, GSK-3b is inactivated (Cook et al., 1996) , resulting in the accumulation of b-catenin. The accumulated bcatenin is translocated into the nucleus and associates with the transcription enhancers of T cell factor/ lymphocyte enhancer binding factor (TCF/LEF) family, and the complex stimulates the expression of genes including c-myc, c-jun, fra-1, and cyclin D1 (Behrens et al., 1996; Molenaar et al., 1996; He et al., 1998; Mann et al., 1999; Tetsu and McCormick, 1999) . Thus, APC and GSK-3b are required for the degradation of b-catenin.
We have identi®ed rat Axin (rAxin) and its homolog, Axil (for Axin like), as GSK-3b-interacting proteins Yamamoto et al., 1998) . Axin is a product of the mouse Fused locus and functions as a negative regulator of the Wnt signaling pathway (Zeng et al., 1997) . Axil has 44% amino acid identity with rAxin and inhibits Xwnt-8-induced axis formation of Xenopus embryos like Axin . Conductin has been identi®ed as a b-catenin binding protein (Behrens et al., 1998) and found to be identical with Axil. We have found that both Axin and Axil bind to not only GSK-3b but also b-catenin directly, and that they promote GSK-3b-dependent phosphorylation of b-catenin . Moreover, we have shown that the regulators of G protein signaling (RGS) domain of rAxin interacts directly with APC, and that expression of rAxin in COS or SW480 cells stimulates the degradation of b-catenin (Kishida et al., , 1999a . Several groups have also reported the similar results (Behrens et al., 1998; Hart et al., 1998; Itoh et al., 1998; Sakanaka et al., 1998; Hamada et al., 1999) . Therefore, it appears that Axin downregulates bcatenin by binding to GSK-3b, b-catenin, and APC, and enhancing GSK-3b-dependent phosphorylation of b-catenin.
Axin also facilitates GSK-3b-dependent phosphorylation of APC, and Axin itself is phosphorylated by GSK-3b (Hart et al., 1998; Ikeda et al., 1998) . It is likely that three substrates, APC, b-catenin, and Axin, form a complex with GSK-3b and that their phosphorylation occurs eciently. However, how the phosphorylation of APC in the Axin complex is regulated is not known. Here we show that the direct binding of APC to Axin enhances the phosphorylation of APC by GSK-3b and that b-catenin enhances the phosphorylation of APC by GSK-3b in the Axin complex. Further, we demonstrate that the heterodimeric form of protein phosphatase 2A (PP2A) binds directly to Axin and that PP2A complexed with Axin dephosphorylates APC which is phosphorylated by GSK-3b. These results suggest that the phosphorylation state of APC is regulated by GSK-3b, b-catenin, and PP2A in the Axin complex.
Results

Effect of Axin on GSK-3b-dependent phosphorylation of APC
The structures of the deletion mutants of APC, Axin, and b-catenin used in the following experiments are shown in Figure 1 .
It has been shown that the region containing 20-aa repeats of APC is phosphorylated by GSK-3b in vitro . We examined whether the region containing 15-aa repeats also has similar characteristics to the 20-aa repeats. APC-(959-1338) and APC-(1211-2075) containing three 15-aa repeats and seven 20-aa repeats, respectively, have possible phosphorylation sites for GSK-3b. Glutathione Stransferase (GST) fused GSK-3b (GST-GSK-3b) phosphorylated both APC mutants, and 0.6 mol and 0.25 mol of phosphates were maximally incorporated into 1 mol of GST-APC-(959-1338) and GST-APC-(1211-2075), respectively. Consistent with the previous observations (Hart et al., 1998) , the phosphorylation of GST-APC-(1211-2075) was enhanced by maltose binding protein (MBP) fused rAxin (MBP-rAxin) in a dosedependent manner (Figure 2a) . However, the phosphorylation of GST-APC-(959-1338) was rather slightly reduced by MBP-rAxin (Figure 2a , these results suggest that direct binding of APC to Axin is necessary for Axin to enhance GSK-3b-dependent phosphorylation of APC. GST-APC-(1211-2075) did not aect the binding of GST-GSK-3b to MBP-rAxin, and GST-GSK-3b did not aect the binding of GST-APC-(1211-2075) to MBP-rAxin, either (Figure 2d ). GSK-3b also phosphorylates rAxin . However, the phosphorylation of MBP-rAxin or GST-APC-(1211-2075) did not aect their interaction (Figure 2e ). Furthermore, GST-APC-(1211-2075) did not signi®-cantly aect the GST-GSK-3b activity to phosphorylate a peptide substrate (GSK peptide 1) designed from glycogen synthase (Figure 2f ). Thus, it is unlikely that the binding of APC to Axin regulates GSK-3b activity. The mechanism that Axin enhances the phosphorylation of APC by GSK-3b may involve the formation of a protein complex in which Axin brings together with GSK-3b and APC.
Effect of b-catenin on GSK-3b-dependent phosphorylation of APC in the presence of Axin
Since b-catenin directly binds to Axin and APC (Polakis, 1997; Ikeda et al., 1998) , the eect of bcatenin on the GSK-3b-dependent phosphorylation of APC was examined. Hexahistidine-tagged b-catenin (His6-b-catenin) did not aect the phosphorylation of GST-APC-(1211-2075) by GST-GSK-3b in the absence of MBP-rAxin (full length), while in its presence His6-b-catenin enhanced the phosphorylation (Figure 3a ). His6-b-catenin also increased the phosphorylation of GST-APC-(1211-2075) by GST-GSK-3b in the pre- 
Interaction of protein phosphatase 2A with Axin
Since low concentrations (100 nM) of okadaic acid increased the phosphorylation of APC in intact cells, PP2A may be involved in the dephosphorylation of APC. Although it has been shown that PP2A directly interacts with casein kinase 2 and CaM kinase IV , 1997; Westphal et al., 1998) , it did not bind to GSK-3b directly (data not shown). Instead, we found that PP2A is present in the Axin complex. When the COS cell lysates expressing Myc-rAxin (full length) were immunoprecipitated with the anti-Myc antibody, the catalytic (C) subunit of endogenous PP2A (PP2Ac) was signi®cantly detected in the rAxin complex although a non-speci®c binding band of PP2A was faintly detected in the control lane ( Figure  5a ). In the reciprocal experiment, little endogenous Axin was co-precipitated with FLAG-PP2Ac in L cells (data not shown). This result suggests that only a small fraction of PP2Ac binds to Axin because PP2Ac has several binding proteins (Zolnierowicz et al., 1996) . Alternatively, the catalytic subunit of PP2A alone may not be sucient for the complex formation of PP2A with Axin. PP2Ac also formed a complex with Myc-rAxin-(298-506) but not with Myc-rAxin-(1-353) (Figure 5b ). PP2Ac was found slightly in the rAxin-(508-832) complex. MBP-rAxin co-precipitated PP2Ac from bovine brain cytosol (Figure 5c ). These results indicate that Axin forms a complex with PP2A in intact cells and in vitro. To examine the direct interaction of PP2A with Axin, PP2A consisting of the C subunit and the 63 kDa regulatory A (A) subunit was puri®ed from human erythrocytes (Usui et al., 1988) (Figure 5d ). The heterodimeric form of PP2A (PP2A(CA)) bound to MBP-rAxin (full length), MBPrAxin-(1-529), and MBP-rAxin-(298-832) but not to MBP-rAxin-(1-229) (Figure 5d ). These results show that rAxin binds directly to PP2A and that the region containing amino acids 298-832 of rAxin is important for the interaction.
Dephosphorylation of APC by PP2A complexed with Axin
Finally, we examined whether PP2A complexed with Axin dephosphorylates the substrates of GSK-3b. After MBP-rAxin and GST-APC-(1211-2075) had been phosphorylated by GSK-3b, PP2A(CA) was incubated with Axin at 48C to form the PP2A/Axin complex, and then free PP2A (CA) was removed. When the sample was incubated at 308C, PP2A(CA) complexed with rAxin dephosphorylated MBP-rAxin and GST-APC-(1211-2075) in a time dependent manner ( Figure 6 ). These results indicate that Axin forms a complex with GSK-3b and PP2A and that the phosphorylation of substrates in the complex is regulated by the protein kinase and the protein phosphatase.
Discussion
We have previously demonstrated that Axin directly binds to GSK-3b and b-catenin and promotes GSK3b-dependent phosphorylation of b-catenin . The region of Axin containing the GSK-3b-and b-catenin-binding sites is sucient for the Axin ability to enhance the phosphorylation of b-catenin by GSK-3b, and deletion of either of the binding regions abrogates its activity . Further, Axin does not aect GSK-3b activity itself . These results suggest that the interaction of Axin with both GSK-3b and b-catenin is necessary and sucient for the signal from GSK-3b to b-catenin. It has also been reported that Axin enhances the GSK3b-dependent phosphorylation of APC in vitro (Hart et al., 1998) . However, whether the interaction of Axin with APC is necessary for enhancing the GSK-3b-dependent phosphorylation of APC is not known. APC has multiple phosphorylation sites for GSK-3b. The regions containing three 15-aa repeats or seven 20-aa repeats are independently phosphorylated by GSK-3b and the latter region (APC-(1211-2075)) but not the former region (APC-(959-1338)) includes the Axinbinding site. We show here that full-length rAxin enhances the phosphorylation of APC-(1211-2075) but not that of APC-(959-1338) by GSK-3b and that the rAxin mutants lacking the APC-binding site (rAxin-(298-506) and rAxin-(298-832)) do not enhance the GSK-3b-dependent phosphorylation of APC. The binding of GSK-3b to Axin does not aect that of APC to Axin, and the interaction of APC with Axin does not aect that of GSK-3b with Axin, either. Phosphorylation of APC or Axin does not aect their binding. Furthermore, APC does not aect the GSK3b activity to phosphorylate GSK peptide 1. Thus, the binding of APC to Axin is necessary for Axin to enhance GSK-3b-dependent phosphorylation of APC and the phosphorylation of APC occurs eciently in the Axin complex. These results explain the observations that APC exhibits a gel band shift by expression of Axin in intact cells. We have also found that b-catenin, but not bcatenin-(423-781) that lacks the Axin-and APCbinding sites, enhances the phosphorylation of APC by GSK-3b in the presence of Axin. Neither the APCbinding site of Axin nor the Axin-binding site of APC is required for this b-catenin activity. The binding of bcatenin to Axin does not aect the binding of GSK-3b to Axin or the GSK-3b activity to phosphorylate GSK peptide 1. Although we do not know the exact mechanism, one possibility is that even though Axin and APC do not bind each other, both proteins form a complex with b-catenin and that in this b-catenin complex, GSK-3b interacted with Axin phosphorylates APC eciently. It has been reported that overexpression of b-catenin increases the phosphorylation of APC in intact cells . Although the reason has not been clari®ed, our results may explain the mechanism. However, the Axin mutant lacking the b-catenin-binding site (rAxin-(1-437)) still induces the gel band shift of APC as well as full-length Axin. One possible explanation might be that overexpression of this Axin mutant, which has the APC-and GSK-3b-binding sites, is sucient for the full phosphorylation of APC in intact cells, thereby b-catenin does not enhance the phosphorylation. Taken together, GSK-3b and its substrates, b-catenin and APC, are simultaneously present in the Axin complex and their phosphorylation occurs eciently in the complex. It has been shown that the phosphorylation of APC enhances its binding to b-catenin and that mutations in possible phosphorylation site of APC for GSK-3b impair the function of APC to downregulate b-catenin (Rubinfeld et al., , 1997 . These results suggest that the phosphorylation of APC is important for its activity to degrade b-catenin. Therefore, enhancement of the phosphorylation of APC by b-catenin in the Axin complex may lead to the degradation of bcatenin.
Our results have shown that PP2A is a binding partner of Axin. PP2A is one of four major serine/ threonine protein phosphatases (Cohen, 1989) . The catalytic (C) subunit of PP2A is always associated with the constant regulatory A (A) subunit. We have used human erythrocyte PP2A that consists of the C and A subunits since it is the major phosphoprotein phosphatase in human erythrocytes (Usui et al., 1988) . Yeast two hybrid experiments have shown that the C subunit of PP2A but not the A subunit interacts with the C-terminal region of mouse Axin, which corresponds to rAxin-(508-713) (Hsu et al., 1999 ). Our results demonstrate that PP2A binds to not only the Cterminal region of rAxin (rAxin-(508-832)) but also its central region of rAxin-(298-506). Therefore, it remains to be clari®ed which subunit of PP2A, the C or A subunit, interacts with the central region of Axin. To the dimeric core of the C and A subunits, a variable third regulatory (B, B'/B56, or PR72/PR59) subunit binds, and it modulates the enzymatic activity of PP2A (Usui et al., 1988; Zolnierowicz et al., 1996) . It is intriguing to speculate that the third subunit regulates the interaction of PP2A with Axin and that Axin itself might be another regulatory protein for PP2A. It has been reported that the B56 subunit of PP2A interacts with APC and that expression of the B56 subunit reduces the level of b-catenin and inhibits the transcription of b-catenin target gene (Seeling et al., 1999) . The results suggest that the third subunit may enhance the phosphorylation of b-catenin by inhibiting the catalytic activity of PP2A.
In summary, Axin forms a complex with protein kinase, its substrates, and protein phosphatase. In the Axin complex, APC is phosphorylated and dephosphorylated by GSK-3b and PP2A, respectively, and bcatenin may modulate the phosphorylation of APC. Thus, the phosphorylation state of APC can be regulated eciently in the Axin complex. We have recently found that Dvl, a dishevelled homolog, directly binds to Axin and that it inhibits GSK-3b- dependent phosphorylation of b-catenin, Axin, and APC in the Axin complex (Kishida et al., 1999b; Yamamoto et al., 1999) . It is likely that Dvl is also involved in the regulation of the phosphorylation state of the substrates. Therefore, Axin may act as a scaold protein and provide well-mediated signal transduction that is precise, fast, and regulated by feedback. The phosphorylation of b-catenin leads to its degradation, while that of Axin stabilizes it (Yamamoto et al., 1999) . Although the phosphorylation of APC may be important for its activity to downregulate b-catenin (Rubinfeld et al., , 1997 , the roles of the phosphorylation of APC are not known. The physiological signi®cance of the phosphorylation of APC in the Wnt signal pathway remains to be clari®ed.
Materials and methods
Materials and chemicals
GSK-3b, APC, b-catenin, and PP2Ac cDNAs were kindly supplied from Drs JR Woodgett (Ontario Cancer Institute, Toronto, Canada), T Akiyama (Osaka University, Suita, Japan), A Nagafuchi (Kyoto University, Kyoto, Japan) and K Yonezawa (Kobe University, Kobe, Japan), respectively. GSK peptide 1 and the anti-GST antibody were provided from Drs CW Turck (University of California, San Francisco, CA, USA) (Murai et al., 1996) and M Nakata (Sumitomo Electronics, Yokohama, Japan), respectively. GST-APC-(1211-2075) and GST-APC-(959-1338) were puri®ed from Sf9 cells. MBP-rAxin, GST-b-catenin, GST-GSK3b, and His6-b-catenin were puri®ed from Escherichia coli according to the manufacturer's instructions. PP2A consisting of the C and A subunits was puri®ed from human erythrocytes as described (Usui et al., 1988) . L cells stably expressing Myc-rAxin were obtained as described (Kishida et al., 1999a) . Bovine brain cytosol was prepared as described (Hinoi et al., 1996) . The anti-Myc antibody was prepared from 9E10 cells. The anti-rabbit Axin and Dvl polyclonal antibodies were generated by immunization with a recombinant fragment of rAxin-(1-229) and Dvl-1-(1-81), respectively. [g-32 P]ATP was obtained from Amersham Pharmacia Biotech Inc. (Buckinghamshire, UK). The anti-PP2Ac, the anti-GSK3b, and the anti-b-catenin antibodies were purchased from Transduction Laboratories (Lexington, KY, USA), and the anti-APC (Ab-1) and anti-FLAG antibodies were purchased from Calbiochem (La Jolla, CA, USA) and Sigma-Aldrich (Steinheim, Germany), respectively. Other materials and chemicals were obtained from the commercial sources.
Plasmid construction
pGEX-2T/b-catenin, pGEX-KG/b-catenin-(423-781), pGEX-2T/GSK-3b, pRSETA/b-catenin, pVIKS/APC-(1211-2075), pBSKS/APC-(1211-2075), pMALc-2/APC-(959-1338), pB-SKS/rAxin (full length), pMALc-2/rAxin (full length), pMALc-2/rAxin-(1-529), pMALc-2/Myc-rAxin-(298-506), pMALc-2/rAxin-(298-832), pBJ-Myc/rAxin (full length), pBJMyc/rAxin-(1-437), pEF-BOS-Myc/rAxin-(298-506), and pEF-BOS-Myc/rAxin-(508-832) were constructed as described Kishida et al., 1998 Kishida et al., , 1999b Yamamoto et al., , 1999 . To construct pGEX-2T/rAxin-(1-229), pBSKS/rAxin (full length) was digested with SacI and SmaI and blunted with T4 polymerase. The fragment encoding rAxin-(1-229) was inserted into the SmaI-cut pGEX-2T. To construct pMALc-2/rAxin-(1-229), pGEX-2T/rAxin-(1-229) was digested with EcoRI, blunted with Klenow fragment, and digested with BamHI. The fragment encoding rAxin-(1-229) was inserted into pMALc-2 which was digested with HindIII, blunted with Klenow fragment, and digested with BamHI. To construct pBJ-Myc/rAxin-(1 ± 353), pBSKS/rAxin (full length) was digested with SmaI and BamHI and blunted with Klenow fragment. The fragment encoding rAxin-(1-353) was inserted into pBJ-Myc which was digested with XbaI and blunted with Klenow fragment. To construct pEF-BOS-Myc/APC-(1211-2075), pBSKS/APC-(1211-2075) was digested with SpeI and SmaI and the fragment encoding APC-(1211-2075) was inserted into the XbaI-and SmaI-cut pEF-BOS-Myc. To construct pVIKS/APC-(9590-1338), pMALc-2/APC-(959-1338) was digested with BamHI and PstI and the fragment encoding APC-(959-1338) was inserted into the BamHI-and PstI-cut pVIKS. in the presence or absence of 400 nM MBP-rAxin (full length) or MBP-rAxin-(298-506) in 30 ml of kinase reaction mixture for 15 min at 308C. The samples were subjected to SDS-± PAGE (polyacrylamide gel electrophoresis) followed by autoradiography. Where speci®ed, the radioactivities of phosphorylated APC were counted.
Enhancement of the phosphorylation of APC by b-catenin and Axin in intact cells
After COS cells transfected with pBJ-, pEF-BOS-, and pUCEFa-derived plasmids were treated with or without 100 nM okadaic acid, the cells were lysed as described (Kikuchi and Williams, 1996) . The lysates (600 mg of protein) were immunoprecipitated with the anti-Myc antibody, and the immunoprecipitates or lysates (40 mg of protein) were probed with the anti-Myc antibody. When the phosphorylation state of endogenous APC was examined, the lysates (40 mg of protein) prepared from L cells stably expressing Myc-rAxin (full length) and wild-type L cells were probed with the anti-APC antibody.
Interaction of PP2A with Axin
COS cells or L cells transfected with pBJ-, pEF-BOS-, or pCMV-derived plasmid were lysed as described (Kikuchi and Williams, 1996) . The lysates (600 mg of protein) were immunoprecipitated with the anti-Myc or anti-FLAG antibody, then the precipitates were probed with the anti-PP2Ac, anti-Myc, anti-Axin, or anti-FLAG antibody. When the interaction of rAxin with PP2A was examined in vitro, MBPrAxin (full length) and its deletion mutants (5 ± 30 pmol) immobilized to amylose resin were incubated with bovine brain cytosol (2.8 mg of protein) or 0.1 mM puri®ed PP2A(CA). MBP fusion proteins were precipitated by centrifugation and the precipitates were probed with the anti-PP2Ac antibody.
Dephosphorylation of APC by PP2A
MBP-rAxin (full length) (5 pmol) immobilized to amylose resin was incubated with 90 nM GST-GSK-3b and 270 nM GST-APC-(1211-2075) in 30 ml of kinase reaction mixture for 30 min at 308C and then the resin was washed extensively. Phosphorylated Axin and APC on the resin was incubated Phosphorylation of APC in the Axin complex S Ikeda et al with 0.1 mM puri®ed PP2A(CA) in 30 ml of reaction mixture (20 mM Tris/HCl [pH 7.5], 1 mM DTT) at 48C for 60 min. Free PP2A(CA) was removed by centrifugation and the resin was incubated in 30 ml of phosphatase reaction mixture (50 mM HEPES/NaOH [pH 7.4], 50 mM MnCl 2 , 0.5 mM DTT, and 0.01% Triton X-100) for the indicated time at 308C. The samples were subjected to SDS ± PAGE and followed by autoradiography.
Other assays
Interaction of APC, b-catenin, and GSK-3b with Axin was assayed as described Kishida et al., 1998) . The GSK-3b activity to phosphorylate GSK peptide 1 was measured as described Yamamoto et al., 1998) .
